Franklin Resources
HUMA icon

Franklin Resources’s Humacyte HUMA Stock Holding History

Franklin Resources’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-431,394
Closed -$902K – 3190
2025
Q2 		$902K Buy
431,394
+1,019
+0.2% +$1.96K ﹤0.01% 2042
2025
Q1 		$734K Sell
430,375
-3,107
-0.7% -$11.7K ﹤0.01% 2100
2024
Q4 		$2.19M Buy
+433,482
New +$2.14M ﹤0.01% 1705

Other funds holding HUMA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Franklin Resources's HUMA Position: Q3 2025 in Review

Franklin Resources sold out of Humacyte (HUMA) in Q3 2025, closing a stake of 431,394 shares — an estimated $902K sold.

Franklin Resources first reported a position in HUMA in Q4 2024 and held it in 3 quarters. The position peaked at $2.19M in Q4 2024. 141 funds tracked by Wall St. Rank hold HUMA as of Q3 2025.

  • Franklin Resources reported no remaining Humacyte position as of Q3 2025 after selling out during the quarter.
  • Franklin Resources sold 431,394 Humacyte shares in Q3 2025, an estimated $902K.
  • Franklin Resources first reported a position in Humacyte in Q4 2024 and held it in 3 quarters.
  • Franklin Resources's Humacyte position peaked at $2.19M in Q4 2024.
  • 141 funds tracked by Wall St. Rank held Humacyte as of Q3 2025.

Based on Franklin Resources's 13F filing for Q3 2025, filed 13 Nov 2025.